Microdosing with psychedelics to self-medicate for ADHD symptoms in adults: A prospective naturalistic study.
Neurosci Appl October 26, 2022 Eline C.H.M. Haijen, Petra P.M. Hurks, Kim P.C. Kuypers 17 citations
Adults with ADHD who microdosed classic psychedelics on their own initiative reported reduced ADHD symptoms and improved well-being after two and four weeks, compared with their baseline. Performance on a time perception task did not improve. Taking conventional ADHD medication alongside microdosing or having other mental health conditions did not alter the effects on symptoms or well-being after four weeks. The authors call for placebo-controlled experiments to determine whether microdosing offers a genuine benefit beyond the placebo effect.